Literature DB >> 9533698

Surface properties of native human plasma lipoproteins and lipoprotein models.

J B Massey1, H J Pownall.   

Abstract

Plasma lipoprotein surface properties are important but poorly understood determinants of lipoprotein catabolism. To elucidate the relation between surface properties and surface reactivity, the physical properties of surface monolayers of native lipoproteins and lipoprotein models were investigated by fluorescent probes of surface lipid fluidity, surface lateral diffusion, and interfacial polarity, and by their reactivity to Naja melanoleuca phospholipase A2 (PLA2). Native lipoproteins were human very low, low-, and subclass 3 high-density lipoproteins (VLDL, LDL, and HDL3); models were 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) or its ether analog in single-bilayer vesicles, large and small microemulsions of POPC and triolein, and reassembled HDL (apolipoprotein A-I plus phospholipid). Among lipoproteins, surface lipid fluidity increased in the order HDL3 < LDL < VLDL, varying inversely with their (protein + cholesterol)/phospholipid ratios. Models resembled VLDL in fluidity. Both lateral mobility in the surface monolayer and polarity of the interfacial region were lower in native lipoproteins than in models. Among native lipoproteins and models, increased fluidity in the surface monolayer was associated with increased reactivity to PLA2. Addition of cholesterol (up to 20 mol%) to models had little effect on PLA2 activity, whereas the addition of apolipoprotein C-III stimulated it. Single-bilayer vesicles, phospholipid-triolein microemulsions, and VLDL have surface monolayers that are quantitatively similar, and distinct from those of LDL and HDL3. Surface property and enzymatic reactivity differences between lipoproteins and models were associated with differences in surface monolayer protein and cholesterol contents. Thus differences in the surface properties that regulate lipolytic reactivity are a predictable function of surface composition.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9533698      PMCID: PMC1302566          DOI: 10.1016/S0006-3495(98)74010-X

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  49 in total

1.  Lateral diffusivity of lipid analogue excimeric probes in dimyristoylphosphatidylcholine bilayers.

Authors:  M Sassaroli; M Vauhkonen; D Perry; J Eisinger
Journal:  Biophys J       Date:  1990-02       Impact factor: 4.033

2.  Kinetics and mechanism of transfer of reduced and carboxymethylated apolipoprotein A-II between phospholipid vesicles.

Authors:  J A Ibdah; S Lund-Katz; M C Phillips
Journal:  Biochemistry       Date:  1990-04-10       Impact factor: 3.162

3.  Lateral diffusion of phospholipids in the lipid surface of human low-density lipoprotein measured with a pyrenyl phospholipid probe.

Authors:  M Vauhkonen; M Sassaroli; P Somerharju; J Eisinger
Journal:  Eur J Biochem       Date:  1989-12-22

4.  Structure and motion of phospholipids in human plasma lipoproteins. A 31P NMR study.

Authors:  D B Fenske; R S Chana; Y I Parmar; W D Treleaven; R J Cushley
Journal:  Biochemistry       Date:  1990-04-24       Impact factor: 3.162

5.  The surface lipid layer of human low density lipoprotein probed by dipyrenyl phospholipids.

Authors:  M Vauhkonen; P Somerharju
Journal:  Chem Phys Lipids       Date:  1990-02       Impact factor: 3.329

6.  Apolipoproteins C-I, C-II, and C-III: kinetics of association with model membranes and intermembrane transfer.

Authors:  B J McKeone; J B Massey; R D Knapp; H J Pownall
Journal:  Biochemistry       Date:  1988-06-14       Impact factor: 3.162

7.  Interaction of ApoA-1 and ApoE-3 with triglyceride-phospholipid emulsions containing increasing cholesterol concentrations. Model of triglyceride-rich nascent and remnant lipoproteins.

Authors:  A Derksen; D M Small
Journal:  Biochemistry       Date:  1989-01-24       Impact factor: 3.162

8.  Parinaroyl and pyrenyl phospholipids as probes for the lipid surface layer of human low density lipoproteins.

Authors:  M Vauhkonen; P Somerharju
Journal:  Biochim Biophys Acta       Date:  1989-08-21

9.  Phase equilibria of cholesterol/dipalmitoylphosphatidylcholine mixtures: 2H nuclear magnetic resonance and differential scanning calorimetry.

Authors:  M R Vist; J H Davis
Journal:  Biochemistry       Date:  1990-01-16       Impact factor: 3.162

10.  Hydrolysis of a phospholipid in an inert lipid matrix by phospholipase A2: a 13C NMR study.

Authors:  S P Bhamidipati; J A Hamilton
Journal:  Biochemistry       Date:  1989-08-08       Impact factor: 3.162

View more
  8 in total

1.  Conversion of lipid transfer inhibitor protein (apolipoprotein F) to its active form depends on LDL composition.

Authors:  Richard E Morton; Diane J Greene
Journal:  J Lipid Res       Date:  2011-09-21       Impact factor: 5.922

2.  VLDL lipolysis products increase VLDL fluidity and convert apolipoprotein E4 into a more expanded conformation.

Authors:  Sarada D Tetali; Madhu S Budamagunta; Catalina Simion; Laura J den Hartigh; Tamás Kálai; Kálmán Hideg; Danny M Hatters; Karl H Weisgraber; John C Voss; John C Rutledge
Journal:  J Lipid Res       Date:  2009-12-03       Impact factor: 5.922

3.  Role of lipids in spheroidal high density lipoproteins.

Authors:  Timo Vuorela; Andrea Catte; Perttu S Niemelä; Anette Hall; Marja T Hyvönen; Siewert-Jan Marrink; Mikko Karttunen; Ilpo Vattulainen
Journal:  PLoS Comput Biol       Date:  2010-10-28       Impact factor: 4.475

4.  Properties of palmitoyl phosphatidylcholine, sphingomyelin, and dihydrosphingomyelin bilayer membranes as reported by different fluorescent reporter molecules.

Authors:  Thomas Nyholm; Matts Nylund; Annu Söderholm; J Peter Slotte
Journal:  Biophys J       Date:  2003-02       Impact factor: 4.033

5.  Properties of the products formed by the activity of serum opacity factor against human plasma high-density lipoproteins.

Authors:  Henry J Pownall; Harry S Courtney; Baiba K Gillard; John B Massey
Journal:  Chem Phys Lipids       Date:  2008-09-16       Impact factor: 3.329

6.  Apolipoprotein F concentration, activity, and the properties of LDL controlling ApoF activation in hyperlipidemic plasma.

Authors:  Richard E Morton; Daniel Mihna
Journal:  J Lipid Res       Date:  2022-01-08       Impact factor: 5.922

7.  Interactions of apolipoprotein A-I with high-density lipoprotein particles.

Authors:  David Nguyen; Margaret Nickel; Chiharu Mizuguchi; Hiroyuki Saito; Sissel Lund-Katz; Michael C Phillips
Journal:  Biochemistry       Date:  2013-03-04       Impact factor: 3.162

8.  Lipoprotein hydrophobic core lipids are partially extruded to surface in smaller HDL: "Herniated" HDL, a common feature in diabetes.

Authors:  Núria Amigó; Roger Mallol; Mercedes Heras; Sergio Martínez-Hervás; Francisco Blanco Vaca; Joan Carles Escolà-Gil; Núria Plana; Óscar Yanes; Lluís Masana; Xavier Correig
Journal:  Sci Rep       Date:  2016-01-18       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.